VF Corp vs State Street SPDR S&P Biotech ETF — how do they compare? VF Corp trades at $14.78 (market cap $5.81B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: VF Corp pays a 2.44% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, VF Corp nearer its low. Which is the better fit depends on your goals.
| VFC | XBI | |
|---|---|---|
Market Cap | $5.81B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $21.55 | $164.28 |
52-Week Low | $12.21 | $86.92 |
Enterprise Value | $10.09B | — |
Dividend Yield | 2.44% | — |
Trailing returns across standard periods
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →